C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress RPT Q1 2026 Earnings Significant EPS Miss as Company Reports Negative Earnings RCMT Q1 2026 Earnings EPS Misses Analyst Expectations as Stock Rebounds ORKA Q1 2026 Earnings NarrowerthanExpected Loss Boosts Shares ARAI Q1 2026 Earnings NarrowerthanExpected Loss Fails to Halt Share Decline OTLY Q1 2026 Earnings Losses Narrow Sharply as Cost Improvements Exceed Expectations